Search Results - "Lui, David Tak‐Wai"
-
1
Serum thrombospondin‐2 level changes with liver stiffness improvement in patients with type 2 diabetes
Published in Clinical endocrinology (Oxford) (01-03-2024)“…Objective Baseline circulating thrombospondin‐2 (TSP2) level was identified as a potential novel hepatic fibrosis biomarker that associates with development…”
Get full text
Journal Article -
2
In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
Published in Journal of diabetes investigation (01-04-2021)“…[...]most NAFLD guidelines recommend the early identification of those at risk of AF, although none has specifically issued recommendations on the best…”
Get full text
Journal Article -
3
Three‐component non‐invasive risk score for undiagnosed diabetes in Chinese people: Development, validation and longitudinal evaluation
Published in Journal of diabetes investigation (01-03-2020)“…Aims/Introduction To develop a new non‐invasive risk score for undiagnosed diabetes in Chinese people, and to evaluate the incident diabetes risk in those with…”
Get full text
Journal Article -
4
Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes
Published in Hepatology (Baltimore, Md.) (01-02-2023)“…Type 2 diabetes (T2D) is common among patients with chronic hepatitis B infection (CHB) and has been associated with increased risk of carcinogenesis,…”
Get full text
Journal Article -
5
Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
Published in Diabetes care (01-09-2021)“…Preclinical studies have suggested that thrombospondin-2 (TSP2) is implicated in liver fibrosis. However, the clinical relevance of TSP2 in nonalcoholic fatty…”
Get full text
Journal Article -
6
Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism
Published in World journal of surgery (01-08-2023)“…Background In severe renal hyperparathyroidism (RHPT), whether administrating Cinacalcet before total parathyroidectomy can reduce post-operative hypocalcemia…”
Get full text
Journal Article -
7
Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines
Published in Frontiers in immunology (11-10-2022)“…Acquiring protective immunity through vaccination is essential, especially for patients with type 2 diabetes who are vulnerable for adverse clinical outcomes…”
Get full text
Journal Article -
8
One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
Published in Journal of diabetes investigation (01-01-2022)“…There is a bidirectional relationship between coronavirus disease 2019 (COVID‐19) and diabetes. Furthermore, the COVID‐19 pandemic has catalyzed the use of…”
Get full text
Journal Article -
9
A territory‐wide study on the impact of COVID‐19 on diabetes‐related acute care
Published in Journal of diabetes investigation (01-09-2020)“…Diabetes is a risk factor for the severity of coronavirus disease 2019 (COVID‐19). Little is known how the COVID‐19 pandemic has disrupted diabetes‐related…”
Get full text
Journal Article -
10
A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification
Published in Frontiers in endocrinology (Lausanne) (02-05-2024)“…The 2022 World Health Organization (WHO) classification of pituitary neuroendocrine tumour (PitNET) supersedes the previous one in 2017 and further…”
Get full text
Journal Article -
11
Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
Published in Diabetes & metabolism journal (01-11-2022)“…Insulin-treated patients with long duration of type 2 diabetes mellitus (T2DM) are at increased risk of ketoacidosis related to sodium-glucose co-transporter 2…”
Get full text
Journal Article -
12
Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation
Published in Frontiers in endocrinology (Lausanne) (22-07-2022)“…The coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which…”
Get full text
Journal Article -
13
Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
Published in Frontiers in endocrinology (Lausanne) (06-01-2023)“…Non-diabetic overweight/obese metabolic dysfunction-associated fatty liver disease (MAFLD) represents the largest subgroup with heterogeneous liver fibrosis…”
Get full text
Journal Article -
14
High‐density lipoprotein in diabetes: Structural and functional relevance
Published in Journal of diabetes investigation (01-07-2024)“…Low levels of high‐density lipoprotein‐cholesterol (HDL‐C) is considered a major cardiovascular risk factor. However, recent studies have suggested a more…”
Get full text
Journal Article -
15
Role of non‐thyroidal illness syndrome in predicting adverse outcomes in COVID‐19 patients predominantly of mild‐to‐moderate severity
Published in Clinical endocrinology (Oxford) (01-09-2021)“…Objective Existing studies reported the potential prognostic role of non‐thyroidal illness syndrome (NTIS), characterized by low triiodothyronine (T3) with…”
Get full text
Journal Article -
16
SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong
Published in Hepatology (Baltimore, Md.) (01-11-2023)“…Type 2 diabetes (T2D) and chronic hepatitis B infection (CHB) are risk factors of HCC. Sodium glucose co-transporter 2 inhibitors (SGLT2i) inhibit HCC…”
Get full text
Journal Article -
17
Effect of type 2 diabetes on the inducible degrader of LDL receptor
Published in Journal of lipid research (01-06-2023)“…The inducible degrader of LDL receptor (IDOL) acts as a post-transcriptional degrader of the LDL receptor (LDLR). IDOL is functionally active in the liver and…”
Get full text
Journal Article -
18
Letter to the Editor: ‘Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS‑CoV‑2 disease’—prognostic significance of non-thyroidal illness syndrome across the whole spectrum of COVID-19 severity
Published in Journal of endocrinological investigation (01-04-2022)Get full text
Journal Article -
19
A territory-wide assessment of the incidence of persistent hypoparathyroidism after elective thyroid surgery and its impact on new fracture risk over time
Published in Surgery (01-11-2021)“…Although persistent (≥6 months) postoperative hypoparathyroidism is often believed to be rare after elective total thyroidectomy, we hypothesized a higher…”
Get full text
Journal Article -
20
Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients
Published in BMC medicine (14-10-2022)“…Background In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction…”
Get full text
Journal Article